Master in Biomedicine and Drug Development

For Master in Biomedicine and Drug Development, the tuition fee is 4,643 USD per year.

Jeju National University offers this master's program in Biomedicine and Drug Development in English, based in Jeju, South Korea. The discipline focuses on the biological mechanisms underlying disease and the process of developing new therapeutic drugs, drawing on coursework in molecular biology, pharmacology, toxicology, and clinical research methods. Students in this field typically examine how diseases develop at the cellular and molecular level, then study how that knowledge translates into the design, testing, and evaluation of new treatments. Coursework often addresses stages of drug development from early discovery through preclinical and clinical testing, alongside related topics such as regulatory science and biomedical research methodology. Laboratory training generally forms a core part of the program, giving students hands-on exposure to techniques used in pharmaceutical and biomedical research settings. The program spans two years across four semesters, with new students able to begin study in March or September. Because instruction is delivered in English, international students can pursue advanced biomedical coursework without first needing to master Korean, although many choose to study the language to support daily life and future career prospects in the country. Graduates of biomedicine and drug development programs commonly pursue roles in pharmaceutical and biotechnology companies, research institutions, or regulatory bodies, or continue toward doctoral study investigating new therapeutic targets or treatment approaches. The program combines foundational biomedical science with an applied focus on how new drugs move from laboratory research to clinical use, preparing graduates for work at the intersection of biology, chemistry, and healthcare in South Korea and internationally.